Ilsung Pharm (003120) — Cash Flow Quality Index
Latest as of March 2026:
-0.46x
Ilsung Pharm (003120) has a Cash Flow Quality Index of -0.46x as of March 2026. Operating cash flow of ₩-731.20 Million is below net income of ₩1.58 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 003120 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.46x
Operating CF / Net Income
Operating Cash Flow
₩-731.20 Million
KRW
Net Income
₩1.58 Billion
KRW
Data as of
Mar 2026
Most recent filing
Ilsung Pharm Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Ilsung Pharm across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Ilsung Pharm (003120) cash flow conversion.
Annual Cash Flow Quality Index for Ilsung Pharm (2013–2025)
Year-by-year earnings quality comparison for Ilsung Pharm.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.33x | ₩3.88 Billion | ₩1.17 Billion | ▲ +1124.3% |
| 2024 | -0.33x | ₩-4.26 Billion | ₩13.09 Billion | ▲ +12.2% |
| 2022 | -0.37x | ₩-38.97 Billion | ₩105.24 Billion | ▼ -176.6% |
| 2020 | 0.48x | ₩1.56 Billion | ₩3.22 Billion | ▼ -26.0% |
| 2019 | 0.65x | ₩4.39 Billion | ₩6.72 Billion | ▼ -87.3% |
| 2018 | 5.12x | ₩15.09 Billion | ₩2.95 Billion | ▲ +32.6% |
| 2017 | 3.86x | ₩10.16 Billion | ₩2.63 Billion | ▲ +137.6% |
| 2016 | -10.28x | ₩-31.01 Billion | ₩3.02 Billion | ▼ -16919.6% |
| 2015 | 0.06x | ₩6.04 Billion | ₩98.85 Billion | ▼ -94.1% |
| 2014 | 1.04x | ₩4.19 Billion | ₩4.03 Billion | ▲ +63.2% |
| 2013 | 0.64x | ₩5.06 Billion | ₩7.96 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.